ARIAD PHARMACEUTICALS INC Net Cash Provided by (Used in) Operating Activities, Continuing Operations
ARIAD PHARMACEUTICALS INC reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$121.44 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2016-11-08
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-09-30 was -$23.69M.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-06-30 was -$32.65M.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-03-31 was -$65.09M.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-12-31 was -$38.59M, a 152.05% decline year-over-year.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$159.25M.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$57.79M.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was -$221.88M.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for fiscal 2012 was -$153.68M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2016-09-30 | -$23.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$56.34M derived: sum of 2 quarters · filed 2016-11-08 | -$121.44M 10-Q · filed 2016-11-08 | -$160.02M derived: sum of 4 quarters · filed 2016-11-08 |
| 2016-06-30 | -$32.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$97.75M 10-Q · filed 2016-08-08 | -$136.33M derived: sum of 3 quarters · filed 2016-08-08 | -$178.38M derived: sum of 4 quarters · filed 2016-11-08 |
| 2016-03-31 | -$65.09M 10-Q · filed 2016-05-10 | -$103.68M derived: sum of 2 quarters · filed 2016-05-10 | -$145.72M derived: sum of 3 quarters · filed 2016-11-08 | -$174.15M derived: sum of 4 quarters · filed 2016-11-08 |
| 2015-12-31 | -$38.59M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$80.63M derived: sum of 2 quarters · filed 2016-11-08 | -$109.05M derived: sum of 3 quarters · filed 2016-11-08 | -$159.25M 10-K · filed 2016-02-29 |
| 2015-09-30 | -$42.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$70.46M derived: sum of 2 quarters · filed 2016-11-08 | -$120.66M 10-Q · filed 2016-11-08 | -$46.52M derived: sum of 4 quarters · filed 2016-11-08 |
| 2015-06-30 | -$28.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$78.62M 10-Q · filed 2016-08-08 | -$4.48M derived: sum of 3 quarters · filed 2016-08-08 | -$40.32M derived: sum of 4 quarters · filed 2016-08-08 |
| 2015-03-31 | -$50.19M 10-Q · filed 2016-05-10 | $23.94M derived: sum of 2 quarters · filed 2016-05-10 | -$11.89M derived: sum of 3 quarters · filed 2016-05-10 | -$55.58M derived: sum of 4 quarters · filed 2016-05-10 |
| 2014-12-31 | $74.14M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $38.30M derived: sum of 2 quarters · filed 2016-02-29 | -$5.38M derived: sum of 3 quarters · filed 2016-02-29 | -$57.79M 10-K · filed 2016-02-29 |
| 2014-09-30 | -$35.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$79.52M derived: sum of 2 quarters · filed 2015-11-06 | -$131.93M 10-Q · filed 2015-11-06 | -$183.50M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$43.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$96.09M 10-Q · filed 2015-08-07 | -$147.66M derived: sum of 3 quarters · filed 2016-02-29 | -$203.83M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$52.41M 10-Q · filed 2015-05-08 | -$103.98M derived: sum of 2 quarters · filed 2016-02-29 | -$160.15M derived: sum of 3 quarters · filed 2016-02-29 | |
| 2013-12-31 | -$51.57M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$107.74M derived: sum of 2 quarters · filed 2016-02-29 | -$221.88M 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$56.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$170.31M 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | -$114.14M 10-Q · filed 2014-08-08 | |||
| 2012-12-31 | -$153.68M 10-K · filed 2015-03-02 |